Canopy Growth CGC
NASDAQ CGC
$1.03 0.00 (-0.48%)
At close: Aug 20, 2026 · 1:00 PM UTC

Canopy Growth (CGC) Cash from Investing Activities (2019 - 2026)

Canopy Growth (CGC) posted Cash from Investing Activities of $15.3 million for Q4 2025, up 3101.35% sequentially from -$508807.3 in Q2 2025, and up 1645.86% YoY from $874704.2 in Q4 2024.

Canopy Growth (CGC) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Canopy Growth has reported Cash from Investing Activities for 7 years, with the latest figure at $15.3 million in Q4 2025.

  • Quarterly Cash from Investing Activities rose 1645.86% year-over-year to $15.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.1 million (up 157.27% YoY) and the FY2026 annual result came in at -$15.6 million, up 53.26% from the prior year.
  • Cash from Investing Activities advanced to $15.3 million in Q4 2025 per CGC's latest filing, from -$508807.3 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $260.8 million in Q3 2021 and troughed at -$438.7 million in Q1 2021.
  • A 5-year average of $11.3 million and a median of $6.3 million in 2023 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2021 and 2025: Cash from Investing Activities slumped 788.29% in 2021, then soared 1645.86% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$19.7 million in 2021, then surged by 605.86% to $99.5 million in 2022, then plunged by 100.45% to -$448801.2 in 2023, then tumbled by 120.11% to -$987871.8 in 2024, then jumped by 1645.86% to $15.3 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $15.3 million, -$508807.3, and -$987871.8 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn -491.00 Mn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Canopy Growth 434.93 Mn 187.92 Mn 16.08 Mn -532,795.93

Historic Data

Download Data
DateValue
Jun 30, 2026 -532,795.93
Jun 30, 2026 -532,795.93
Dec 31, 2025 15.27 Mn
Dec 31, 2025 15.27 Mn
Jun 30, 2025 -508,807.31
Jun 30, 2025 -508,807.31
Dec 31, 2024 -987,871.81
Dec 31, 2024 -987,871.81
Sep 30, 2024 -1.63 Mn
Sep 30, 2024 -1.63 Mn
Jun 30, 2024 -31.58 Mn
Jun 30, 2024 -31.58 Mn
Mar 31, 2024 12.98 Mn
Mar 31, 2024 12.98 Mn
Dec 31, 2023 -448,801.21
Dec 31, 2023 -448,801.21
Sep 30, 2023 44.86 Mn
Sep 30, 2023 44.86 Mn
Jun 30, 2023 106.14 Mn
Jun 30, 2023 106.14 Mn